特此公告。 招商基金管理有限公司 为促进招商中证全指医疗器械交易型开放式指数证券投资基金（以下简称"医疗器械指数ETF"）的市场 流动性和平稳运行，根据《深圳证券交易所证券投资基金业务指引第2号一一流动性服务》等有关规 定，自2026年2月2日起，本公司选定东方证券股份有限公司为医疗器械指数ETF（159898）的流动性服 务商。 2026年2月2日 MACD金叉信号形成，这些股涨势不错！ ...

Macro - The People's Bank of China plans to implement a moderately loose monetary policy by 2026, establishing a mechanism to provide liquidity to non-bank institutions under specific scenarios to support capital markets [1] Satellite Internet - The first commercial rocket company in China, Kegong Rocket, is set to change ownership with an overall valuation of approximately 11.2 billion yuan [2] Semiconductor - NVIDIA's BlueField-4 is expected to reconstruct the AI storage hierarchy, potentially opening up new demand for NAND [3] - NVIDIA's CEO Jensen Huang announced at CES that the era of "physical AI" has arrived [7] Pricing Strategies - Seagate plans to increase product prices by 10% each quarter [4] Non-ferrous Metals - China has announced a ban on all dual-use items for military purposes to Japan, affecting critical metal materials such as rare earths, tungsten, molybdenum, indium, lithium, and titanium alloys [5] Artificial Intelligence - Market discussions regarding NVIDIA's next-generation Rubin platform specifications indicate no issues with downgrading [6] Robotics - Tesla's official recruitment platform has posted job openings related to "covering materials and soft products" for the Optimus robot [8] New Energy - A meeting for the power and energy storage battery industry is scheduled for January 7 [9] - Feedback from the industry indicates extremely low inventory levels of lithium carbonate and strong demand, with two listed companies in lithium iron phosphate confirming price increases [10] - Australia has significantly increased subsidies for home battery systems [11] - The organic silicon industry plans to intensify production cuts [12] Brain-Computer Interface - The brain-computer interface "unicorn" Qiangna Technology has completed a financing round of 2 billion yuan [13] Intelligent Driving - NVIDIA has released an open-source model family for autonomous driving, aimed at addressing long-tail issues and accelerating the implementation of intelligent driving [14] Market Dynamics - Guosheng Technology and Jiamei Packaging are under suspension for verification; Fenglong Co. has issued a warning about stock fluctuations; several commercial aerospace and brain-computer interface companies have released announcements regarding stock movements [15] - In December 2025, the number of new A-share accounts opened on the Shanghai Stock Exchange increased by approximately 9% month-on-month and surged by 30.55% year-on-year [15] Strategy Observation - On Tuesday, trading volume reached 2.81 trillion yuan, with a significant increase in market sentiment; however, rapid gains and the activation of financial sectors may raise concerns about the "healthy bull" rhythm [16] - The regulatory authorities have released signals of concern through suspensions and announcements, which may provide divergence opportunities for the market, but substantial cooling requires sustained measures [16] - Sectors such as non-ferrous metals, non-bank financials, and chemicals led the gains, indicating active institutional investment [16] - The thematic sectors, particularly those related to Musk's industries (intelligent driving and robotics), performed actively; while the semiconductor sector (e.g., storage) has solid logic, it has not yet become a focal point, with potential for future attention [16] - Currently, large funds tend to operate around mainline capacity varieties [16]

Group 1 - The core viewpoint is that medical device stocks are experiencing significant gains, with companies like United Imaging Healthcare rising over 11%, and others such as Mindray, Aimeike, Yuyue Medical, and BGI Genomics increasing by more than 4% [1] - Multiple medical-related ETFs have also seen an increase of over 3% due to market influences [1] Group 2 - Specific ETF performance includes: - Medical Device Index ETF (code: 159898) at 0.616, up 3.88% - Huatai-PineBridge Medical ETF (code: 516790) at 0.659, up 3.62% - Medical Services ETF (code: 516610) at 0.549, up 3.58% - Medical Device ETF Fund (code: 159797) at 0.864, up 3.23% - Other ETFs also showing positive growth [2] - Analysts indicate that increasing internationalization will provide more investment opportunities in the medical device sector, with several companies expected to see high growth in international business by 2025, leading to a sustained increase in revenue share [2] - The Hong Kong stock market has shown strong performance in medical devices this year, which is expected to reflect positively on the A-share market, suggesting that investment opportunities in both markets will continue to be prominent [2]

Core Viewpoint - The medical device sector is experiencing a positive trend, supported by government policies and innovation in technology, particularly in AI and robotics, which are expected to drive long-term investment opportunities [1][2]. Group 1: Market Performance - On August 26, the three major stock indices continued to rise, with the medical device index ETF (159898) experiencing a slight decline of 0.32% in the afternoon [1]. - The ETF saw an inflow of funds amounting to 10 million, indicating a sustained trend of capital accumulation [1]. Group 2: Regulatory and Policy Support - The National Medical Products Administration (NMPA) has approved 52 innovative medical device products this year, bringing the total to 367 [1]. - The NMPA has introduced ten measures to support key areas in medical device innovation, including medical robotics, high-end medical imaging, AI medical devices, and new biological materials [1]. Group 3: Industry Outlook - The AI wave is expected to catalyze multi-dimensional development in the industry, transitioning from scale expansion to higher-level development stages [1]. - The industry is anticipated to benefit from enhanced health awareness among the public and ongoing consumption stimulus policies, particularly for innovative ophthalmic and home medical device companies [2]. - The impact of centralized procurement is gradually being digested, with increasing domestic market share in orthopedic consumables and electrophysiology [2].

Core Viewpoint - The medical device sector is experiencing significant growth, driven by supportive policies and technological advancements, particularly in brain-computer interface technology and commercial health insurance development [2][4]. Group 1: Medical Device Sector Performance - Medical device stocks such as Mindray, Sanxin Medical, and Maipu Medical have seen increases of over 10%, while others like Xiangyu Medical and Shanhai Mountain have risen over 5%, contributing to the overall rise of medical device ETFs [1]. - The medical device market in China surpassed 1,032.8 billion yuan in 2023, maintaining its position as the second-largest globally, supported by policy backing, aging population, and technological innovation [3]. Group 2: Policy Developments - A joint initiative by seven government departments aims to promote the innovation and development of brain-computer interface technology, targeting breakthroughs by 2027 and establishing a competitive industry ecosystem by 2030 [2][4]. - Shanghai has introduced 18 measures to support the development of commercial health insurance and innovative medical devices, focusing on expanding coverage and integrating new medical technologies into insurance plans [3]. Group 3: Market Outlook - The medical device industry is expected to benefit from the integration of innovative products into insurance coverage, which may enhance market confidence and stimulate growth [5]. - The focus on commercial health insurance and innovative medical devices is anticipated to create new opportunities for investment in the sector, particularly in areas like AI and high-end domestic equipment [3][4].

Group 1 - The core viewpoint is that the medical device sector is experiencing a strong performance, with notable increases in stock prices for companies like Lepu Medical, Mindray, and United Imaging, indicating a positive market trend [1][2] - Medical-related ETFs have also seen a rise of approximately 2%, reflecting the overall strength of the sector [1][2] - Analysts suggest that increasing internationalization will provide more investment opportunities in the medical device sector, with several companies expected to achieve high growth in international business by 2025 [2] Group 2 - The performance of Hong Kong's medical device stocks has been strong this year, which is anticipated to influence the A-share market positively [2] - The investment opportunities in both A-share and Hong Kong medical device sectors are expected to continue to be prominent [2]

Core Viewpoint - The medical device sector is experiencing a rise, with notable increases in stocks such as United Imaging Healthcare, New Industry, BGI Genomics, and Jiuan Medical, all rising over 3% [1] Group 1: Stock Performance - The ETF tracking the CSI All Share Medical Device Index has increased by approximately 3% [1] - Specific ETFs in the medical device sector have shown significant gains, with the Medical Device ETF Fund at 0.830, up 3.23%, and the Medical Device Index ETF at 0.588, up 3.16% [2] Group 2: Future Opportunities - Analysts indicate that increasing internationalization will provide more investment opportunities in the medical device sector, with several companies expected to see high growth in international business by 2025 [2] - The performance of Hong Kong's medical device stocks has been strong this year, which may positively influence the A-share market, suggesting that investment opportunities in both A-shares and Hong Kong's medical device sector will continue to emerge [2]

Core Viewpoint - The recent optimization of centralized procurement policies by the National Medical Insurance Administration is expected to positively impact the medical device sector, leading to potential performance reversals for previously restricted high-value consumables and in vitro diagnostics [1][9]. Group 1: Policy Changes - The 11th batch of centralized procurement has been initiated, with new rules optimizing the calculation of price differences, moving away from solely relying on the lowest bid as a reference [1][9]. - Companies that submit the lowest bids must now provide a rationale for their pricing and commit to not pricing below cost [1][9]. Group 2: Market Outlook - Zhongyou Securities anticipates that the centralized procurement policy will extend from pharmaceuticals to medical devices, suggesting a recovery in performance for high-value consumables and in vitro diagnostics due to policy improvements [1][9]. - The medical device sector is expected to benefit from a recovery in procurement activities this year, with the third quarter potentially marking a performance turning point for the sector [1][9]. Group 3: Investment Opportunities - Huajin Securities indicates that the medical device sector is experiencing a policy shift, with improved profitability prospects for related companies and potential valuation recovery, as the sector is currently undervalued [1][9]. - The medical device index ETF (159898) has attracted significant investment interest, with over 37 million net subscriptions in the past 10 days, indicating strong market confidence [1][9]. Group 4: Historical Performance - The CSI Medical Device Index has shown a cumulative increase of nearly 953% since its base date of December 31, 2004, translating to an annualized return of 12.51%, outperforming major indices like the Shanghai Composite and CSI 500 [2][6][7]. - The index's performance highlights the high barriers and value characteristics of the medical device industry, which has consistently delivered strong results in the secondary market [6][8].

ETF Industry News - Major indices experienced fluctuations with the Shanghai Composite Index down by 0.94%, Shenzhen Component down by 0.85%, and ChiNext down by 1.18% [1] - Several ETFs in the pharmaceutical and biotechnology sectors saw gains, including the Tianhong Innovative Drug ETF (517380.SH) up by 2.35%, E Fund Medical ETF (159847.SZ) up by 0.80%, and Medical Device Index ETF (159898.SZ) up by 0.78% [1] - Conversely, multiple ETFs in the computer sector declined, with the Financial Technology ETF (159851.SZ) down by 2.54% and Big Data ETF (515400.SH) down by 2.04% [1] Gold Market Activity - International gold prices returned to the $3,300 per ounce mark, leading to increased interest in gold-related assets [1] - On May 22, several gold ETFs recorded gains, with a weekly increase exceeding 5% [1] - Notably, on May 21, some gold ETFs saw significant inflows, with one ETF receiving over 100 million yuan in net inflow [1] ETF Product Development - The growing variety of ETF products has prompted public fund institutions to introduce ETF-FOF products to help investors select suitable ETFs [2] - ETF-FOF products are noted for their higher capital efficiency and lower fees compared to traditional FOF products, with the ability to disclose valuations like ordinary funds [2] - The complexity of the ETF market requires public fund institutions to enhance their macroeconomic research and asset allocation capabilities [2] Market Overview - On May 23, the three major indices collectively declined, with the Shanghai Composite Index closing at 3,348.37 points and the Shenzhen Component at 10,132.41 points [2] - The Nikkei 225 and Hang Seng Index showed positive performance, with daily changes of 0.47% and 0.24%, respectively [2] Sector Performance - In the A-share market, the automotive, pharmaceutical, and basic chemical sectors performed well, with daily increases of 0.42%, 0.42%, and 0.05%, respectively [6] - The computer, comprehensive, and media sectors lagged behind, with daily declines of -1.97%, -1.84%, and -1.79% [6] ETF Performance Summary - The best-performing ETF category today was the currency-type ETFs, with an average daily change of 0.01%, while the worst was the thematic stock index ETFs, with an average decline of -0.86% [7] - Top-performing ETFs included the Tianhong Innovative Drug ETF (517380.SH) with a daily increase of 2.35% and the Automotive ETF (159512.SZ) with a 2.01% rise [9][10] Trading Volume Insights - The top three ETFs by trading volume were the CSI 300 ETF (510300.SH) with a volume of 3.392 billion yuan, A500 ETF (512050.SH) with 2.807 billion yuan, and A500 Index ETF (159351.SZ) with 2.530 billion yuan [12][13]